• 1
    Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 59: 42137.
  • 2
    Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 108797.
  • 3
    Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996; 2: 20915.
  • 4
    Osterud B, Flaegstad T. Increased thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavorable prognosis. Thromb Haemost 1983; 49: 57.
  • 5
    Owens AP III, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108: 128497.
  • 6
    Butenas S, Amblo-Krudysz J, Mann KG. Posttranslational modifications of tissue factor. Front Biosci (Elite Ed) 2012; 4: 38191.
  • 7
    Osterud B, Bjorklid E. Tissue factor in blood cells and endothelial cells. Front Biosci (Elite Ed) 2012; 4: 28999.
  • 8
    Maynard JR, Heckman CA, Pitlick FA, Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest 1975; 55: 81422.
  • 9
    Broze GJ Jr. Binding of human factor VII and VIIa to monocytes. J Clin Invest 1982; 70: 52635.
  • 10
    Fair DS, MacDonald MJ. Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem 1987; 262: 116928.
  • 11
    Le DT, Rapaport SI, Rao LVM. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem 1992; 267: 1544754.
  • 12
    Sakai T, Lund-Hansen T, Paborsky L, Pedersen AH, Kisiel W. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82) implications for the initiation of the extrinsic pathway of blood coagulation. J Biol Chem 1989; 264: 99808.
  • 13
    Walsh JD, Geczy CL. Discordant expression of tissue factor antigen and procoagulant activity on human monocytes activated with LPS and low dose cycloheximide. Thromb Haemost 1991; 66: 5528.
  • 14
    Ploplis VA, Edgington TS, Fair DS. Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor. J Biol Chem 1987; 262: 95038.
  • 15
    Bach R, Rifkin DB. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci USA 1990; 87: 69959.
  • 16
    Rao LVM, Kothari H, Pendurthi UR. Tissue factor: mechanisms of decryption. Front Biosci 2012; 4: 151327.
  • 17
    Bach RR, Monroe D. What is wrong with the allosteric disulfide bond hypothesis? Arterioscler Thromb Vasc Biol 2009; 29: 19978.
  • 18
    Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 2003; 44: 23342.
  • 19
    Zwaal RF, Bevers EM, Comfurius P, Rosing J, Tilly RH, Verhallen PF. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol Cell Biochem 1989; 91: 2331.
  • 20
    Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005; 62: 97188.
  • 21
    Chargaff E. Remarks on the role of lipids in blood coagulation. Arch Sci Physiol 1948; 2: 26971.
  • 22
    Nemerson Y. The phospholipid requirement of tissue factor in blood coagulation. J Clin Invest 1968; 47: 7280.
  • 23
    Bjorklid E, Storm E. Purification and some properties of the protein component of tissue thromboplastin from human brain. Biochem J 1977; 165: 8996.
  • 24
    Krishnaswamy S, Field KA, Edgington TS, Morrissey JH, Mann KG. Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem 1992; 267: 2611020.
  • 25
    Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a “prima ballerina”. Thromb Haemost 1995; 74: 717.
  • 26
    Neuenschwander PF, Bionco-Fisher E, Rezaie AR, Morrissey JH. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry 1995; 34: 1398893.
  • 27
    Shaw AW, Pureza VS, Sligar SG, Morrissey JH. The local phospholipid environment modulates the activation of blood clotting. J Biol Chem 2007; 282: 655663.
  • 28
    Tavoosi N, Davis-Harrison RL, Pogorelov TV, Ohkubo YZ, Arcario MJ, Clay MC, Rienstra CM, Tajkhorshid E, Morrissey JH. Molecular determinants of phospholipid synergy in blood clotting. J Biol Chem 2011; 286: 2324753.
  • 29
    Wolberg AS, Monroe DM, Roberts HR, Hoffmann MR. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagul Fibrinolysis 1999; 10: 20110.
  • 30
    Kunzelmann-Marche C, Satta N, Toti F, Zhang Y, Nawroth PP, Morrissey JH, Freyssinet J-M. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface. Thromb Haemost 2000; 83: 2829.
  • 31
    Chen VM, Ahamed J, Versteeg HH, Berndt MC, Ruf W, Hogg PJ. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry 2006; 45: 120208.
  • 32
    Kothari H, Nayak RC, Rao LV, Pendurthi UR. Cystine186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption. Blood 2010; 115: 427383.
  • 33
    Le DT, Rapaport SI, Rao LVM. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X in fibroblast monolayers after their exposure to N-ethylmalemide. Thromb Haemost 1994; 72: 84855.
  • 34
    Henriksson CE, Klingenberg O, Ovstebo R, Joo GB, Westvik AB, Kierulf P. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis. Thromb Haemost 2005; 94: 123644.
  • 35
    Carson SD, Johnson DR. Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. Blood 1990; 76: 3617.
  • 36
    Greeno EW, Bach R, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996; 75: 2819.
  • 37
    Carson SD. Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane. Blood Coagul Fibrinolysis 1996; 7: 30313.
  • 38
    Carson SD, Kuszynski CA, Pirruccello SJ. Fibroblasts restrict tissue factor from vesicles which form in response to low concentrations of detergent. Blood Coagul Fibrinolysis 1996; 7: 31424.
  • 39
    Rao LVM, Robinson T, Hoang AD. Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: a kinetic study. Thromb Haemost 1992; 67: 6549.
  • 40
    Fu Y, Zhou J, Li H, Cao F, Su Y, Fan S, Li Y, Wang S, Li L, Gilbert GE, Shi J. Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release. Thromb Haemost 2010; 104: 123541.
  • 41
    Pendurthi UR, Ghosh S, Mandal SK, Rao LV. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood 2007; 110: 39008.
  • 42
    Zhou J, Shi J, Hou J, Cao F, Zhang Y, Rasmussen JT, Heegaard CW, Gilbert GE. Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia. J Thromb Haemost 2010; 8: 77382.
  • 43
    Kothari H, Rao LVM, Pendurthi UR. Cys186-Cys209 disulfide-mutated tissue factor does not equal cryptic tissue factor: no impairment in decryption of disulfide mutated tissue factor. Blood 2010; 116: 5023.
  • 44
    van Heerde WL, De Groot PG, Reutelingsperger CPM. The complexity of the phospholipid binding protein annexin v. Thromb Haemost 1995; 73: 1729.
  • 45
    Ravanat C, Archipoff G, Beretz A, Freund G, Cazenave JP, Freyssinet JM. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells. Biochem J 1992; 282: 713.
  • 46
    Stuart MC, Reutelingsperger CP, Frederik PM. Binding of annexin V to bilayers with various phospholipid compositions using glass beads in a flow cytometer. Cytometry 1998; 33: 4149.
  • 47
    Rao LVM, Tait JF, Hoang AD. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb Res 1992; 67: 51731.
  • 48
    Popescu NI, Lupu C, Lupu F. Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure. Blood 2010; 116: 9931001.
  • 49
    Dachary-Prigent J, Freyssinet J, Pasquet J, Carron J, Nurder AT. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 255465.
  • 50
    Smeets EF, Comfurius P, Bevers EM, Zwaal RF. Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles. Thromb Res 1996; 81: 41926.
  • 51
    Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989; 264: 79449.
  • 52
    Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry 1986; 25: 400720.
  • 53
    Forman SD, Nemerson Y. Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic system. Proc Natl Acad Sci USA 1986; 83: 46759.
  • 54
    Hathcock JJ, Rusinova E, Gentry RD, Andree H, Nemerson Y. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions. Biochemistry 2005; 44: 818797.
  • 55
    Ruf W, Rehemtulla A, Morrissey JH, Edgington TS. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 1991; 266: 215866.
  • 56
    Bom VJJ, Bertina RM. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochem J 1990; 265: 32736.
  • 57
    Ohkubo YZ, Morrissey JH, Tajkhorshid E. Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor. J Thromb Haemost 2010; 8: 104453.
  • 58
    Morrissey JH, Tajkhorshid E, Rienstra CM. Nanoscale studies of protein-membrane interactions in blood clotting. J Thromb Haemost 2011; 9(Suppl. 1): 1627.
  • 59
    Morrissey JH, Tajkhorshid E, Sligar SG, Rienstra CM. Tissue factor/factor VIIa complex: role of the membrane surface. Thromb Res 2012; 129(Suppl. 2): S810.
  • 60
    Sen P, Neuenschwander PF, Pendurthi UR, Rao LV. Analysis of factor VIIa binding to relipidated tissue factor by surface plasmon resonance. Blood Coagul Fibrinolysis 2010; 21: 3769.
  • 61
    Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood 1997; 89: 32706.
  • 62
    Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006; 26: 45661.
  • 63
    Huang Q, Neuenschwander PF, Rezaie AR, Morrissey JH. Substrate recognition by tissue factor-factor VIIa. J Biol Chem 1996; 271: 217527.
  • 64
    Kirchhofer D, Lipari MT, Moran P, Eigenbrot C, Kelley RF. The tissue factor region that interacts with substrates factor IX and Factor X. Biochemistry 2000; 39: 73807.
  • 65
    Rao LVM, Ruf W. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor. Biochemistry 1995; 34: 1086771.
  • 66
    Ahamed J, Versteeg HH, Kerver M, Chen VM, Mueller BM, Hogg PJ, Ruf W. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA 2006; 103: 139327.
  • 67
    Pendurthi UR, Allen KE, Ezban M, Rao LVM. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VII.tissue factor-induced signal transduction. J Biol Chem 2000; 275: 1463241.
  • 68
    Petersen LC, Albrektsen T, Hjorto GM, Kjalke M, Bjorn SE, Sorensen BB. Factor VIIa/tissue factor-dependent gene regulation and pro-coagulant activity: effect of factor VIIa concentration. Thromb Haemost 2007; 98: 90911.
  • 69
    Balasubramanian K, Mirnikjoo B, Schroit AJ. Regulated externalization of phosphatidylserine at the cell surface: implications for apoptosis. J Biol Chem 2007; 282: 1835764.
  • 70
    Liang HP, Brophy TM, Hogg PJ. Redox properties of the tissue factor Cys186-Cys209 disulfide bond. Biochem J 2011; 437: 45560.
  • 71
    Rehemtulla A, Ruf W, Edgington TS. The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem 1991; 266: 102949.
  • 72
    van den Hengel LG, Kocaturk B, Reitsma PH, Ruf W, Versteeg HH. Complete abolishment of coagulant activity in monomeric disulfide-deficient tissue factor. Blood 2011; 118: 34468.
  • 73
    van den Hengel LG, Osanto S, Reitsma PH, Versteeg HH Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide bond. Haematologica 2012; DO1:10.3324/haematol.2012.069997.
  • 74
    Donate F, Kelly CR, Ruf W, Edgington TS. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X. Biochemistry 2000; 39: 1146776.
  • 75
    Versteeg HH, Ruf W. Thiol pathways in the regulation of tissue factor prothrombotic activity. Curr Opin Hematol 2011; 18: 3438.
  • 76
    Rao LV, Kothari H, Pendurthi UR. Tissue factor encryption and decryption: facts and controversies. Thromb Res 2012; 129(Suppl. 2): S137.
  • 77
    Ruf W. Role of thiol pathways in TF procoagulant regulation. Thromb Res 2012; 129(Suppl. 2): S112.
  • 78
    Liang HPH, Hogg PJ. Critical importance of the cell system when studying tissue factor de-encryption. Blood 2008; 112: 9123.
  • 79
    Furlan-Freguia C, Marchese P, Gruber A, Ruggeri ZM, Ruf W. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest 2011; 121: 293244.
  • 80
    Reinhardt C, von Bruhl ML, Manukyan D, Grahl L, Lorenz M, Altmann B, Dlugai S, Hess S, Konrad I, Orschiedt L, Mackman N, Ruddock L, Massberg S, Engelmann B. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 2008; 118: 111022.
  • 81
    Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 2008; 118: 112331.
  • 82
    Bach R, Konigsberg WH, Nemerson Y. Human tissue factor contains thioester-linked palmitate and sterate on the cytoplasmic half-cystine. Biochemistry 1988; 14: 422731.
  • 83
    Paborsky LR, Harris RJ. Post-translational modifications of recombinant human tissue factor. Thromb Res 1990; 60: 36776.
  • 84
    Krudysz-Amblo J, Jenny RJ, Knigy T, Matthews D, Mann KG, Butenas S. Allosteric cysteine oxidation does not play a role in tissue factor decryption. Blood 2011; 118: 1174.
  • 85
    Kaneko H, Kakkar VV, Scully MF. Mercury compounds induce a rapid increase in procoagulant activity of monocyte-like U937 cells. Br J Haematol 1994; 87: 8793.
  • 86
    Ruf W, Versteeg HH. Tissue factor mutated at the allosteric Cys186-Cys209 disulfide bond is severely impaired in decrypted procoagulant activity. Blood 2010; 116: 5001.
  • 87
    Roy S, Paborsky LR, Vehar GA. Self-association of tissue factor as revealed by chemical crosslinking. J Biol Chem 1991; 266: 46658.
  • 88
    Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell 2006; 126: 85567.
  • 89
    Pitlick FA. Concanavalin A inhibits tissue factor coagulant activity. J Clin Invest 1975; 55: 1759.
  • 90
    Stone MJ, Ruf W, Miles DJ, Edgington TS, Wright PE. Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from E. coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J 1995; 310: 60514.
  • 91
    Krudysz-Amblo J, Jennings ME, Mann KG, Butenas S. Carbohydrates and activity of natural and recombinant tissue factor. J Biol Chem 2010; 285: 337182.
  • 92
    Kothari H, Rao LV, Pendurthi UR. Glycosylation of tissue factor is not essential for its transport or functions. J Thromb Haemost 2011; 9: 151120.
  • 93
    Shands JW Jr, . Macrophage factor X activator formation: metabolic requirements for synthesis of components. Blood 1985; 65: 16975.
  • 94
    Bona R, Lee E, Rickles F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res 1987; 48: 487500.
  • 95
    Goldstein IJ, Hollerman CE, Smith EE. Protein-carbohydrate interaction.II. Inhibition studies on the interaction of concanavalin A with polysaccharides. Biochemistry 1965; 4: 87683.
  • 96
    Paborsky LR, Tate KM, Harris RJ, Yansura DG, Band L, McCray G, Gorman CM, O’Brien DP, Chang JY, Swartz JR, Fung VP, Thomas JN, Vehar GA. Purification of recombinant human tissue factor. Biochem J 1989; 28: 80727.
  • 97
    Krudysz-Amblo J, Jennings ME, Matthews DE, Mann KG, Butenas S. Differences in the fractional abundances of carbohydrates of natural and recombinant human tissue factor. Biochim Biophys Acta 2011; 1810: 398405.
  • 98
    Van den Besselaar AMHP, Bertina RM. Interaction of thromboplastin apoprotein of different tissues with concanavalin A – evidence for heterogeneous glycosylation of the human apoprotein. Thromb Haemost 1984; 52: 1925.
  • 99
    Varki A, Kannagi R, Toole BP. Glycosylation changes in cancer. In: Varki A, Cummings RD, Eske JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etlzer ME, eds. Essentials of glycobiology, 2nd edn. New York: CSH Press, 2009: 61732.
  • 100
    Cohen P. The regulation of protein function by multisite phosphorylation – a 25 year update. Trends Bichem Sci 2000; 25: 596601.
  • 101
    Pawson T, Scott JD. Protein phosphorylation in signaling – 50 years and counting. Trends Biochem Sci 2005; 30: 28690.
  • 102
    Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992; 70: 37587.
  • 103
    Via A, Diella F, Gibson TJ, Helmer-Citterich M. From sequence to structural analysis in protein phosphorylation motifs. Front Biosci 2011; 16: 126175.
  • 104
    Zioncheck TF, Roy S, Vehar GA. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem 1992; 267: 35614.
  • 105
    Dorfleutner A, Ruf W. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. Blood 2003; 102: 39984005.
  • 106
    Ahamed J, Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem 2004; 279: 2303844.
  • 107
    Mody RS, Carson SD. Tissue factor cytoplasmic domain peptide is multiply phosphorylated in vitro. Biochemistry 1997; 36: 786975.
  • 108
    Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, Carmeliet P, Mueller BM, Friedlander M, Ruf W. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 2004; 10: 5029.
  • 109
    Dorfleutner A, Hintermann E, Tarui T, Takada Y, Ruf W. Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. Mol Biol Cell 2004; 15: 441625.
  • 110
    Ryden L, Grabau D, Schaffner F, Jonsson PE, Ruf W, Belting M. Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer. Int J Cancer 2010; 126: 233040.
  • 111
    Sorensen BB, Freskgard P-O, Nielsen LS, Rao LVM, Ezban M, Petersen LC. Factor VIIa-induced p44/42 mitogen-activated kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem 1999; 274: 2134954.
  • 112
    Wolberg AS, Kon RH, Monroe DM, Ezban M, Roberts HR, Hoffman M. Deencryption of cellular tissue factor is independent of its cytoplasmic domain. Biochem Biophys Res Commun 2000; 272: 3326.
  • 113
    Carson SD, Bromberg ME. Tissue factor encryption/de-encryption is not altered in the absence of the cytoplasmic domain. Thromb Haemost 2000; 84: 65763.
  • 114
    Egorina EM, Sovershaev MA, Osterud B. Regulation of tissue factor procoagulant activity by post-translational modifications. Thromb Res 2008; 122: 8317.
  • 115
    Collier ME, Ettelaie C. Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor. J Biol Chem 2011; 286: 1197784.
  • 116
    Milligan G, Parenti M, Magee AI. The dynamic role of palmitoylation in signal transduction. Trends Biochem Sci 1995; 20: 1817.
  • 117
    Resh MD. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1999; 1451: 116.
  • 118
    Mumby SM. Reversible palmitoylation of signaling proteins. Curr Opin Cell Biol 1997; 9: 14854.
  • 119
    Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 56972.
  • 120
    Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 1999; 19: 7289304.
  • 121
    Schlegel A, Lisanti MP. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction. Cytokine Growth Factor Rev 2001; 12: 4151.
  • 122
    Anderson RGW. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 1993; 90: 1090913.
  • 123
    Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1: 319.
  • 124
    Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 2002; 110: 597603.
  • 125
    Mulder AB, Smit JW, Bom VJJ, Blom NR, Ruiters MHJ, Halie R, van der Meer J. Association of smooth muscle cell tissue factor with caveolae. Blood 1996; 88: 130613.
  • 126
    Mulder AB, Smit JW, Bom VJJ, Blom NR, Halie MR, van der Meer J. Association of endothelial tissue factor and thrombomodulin with caveolae. Blood 1996; 88: 36673670M.
  • 127
    Mandal SK, Pendurthi UR, Rao LVM. Cellular localization and trafficking of tissue factor. Blood 2006; 107: 474653.
  • 128
    Awasthi V, Mandal SK, Papanna V, Rao LV, Pendurthi UR. Modulation of tissue factor-factor VIIa signaling by lipid rafts and caveolae. Arterioscler Thromb Vasc Biol 2007; 27: 144755.
  • 129
    Sevinsky JR, Rao LVM, Ruf W. Ligand induced protease receptor translocation into caveolae: a mechanism regulating cell surface proteolysis of the tissue factor dependent coagulation pathway. J Cell Biol 1996; 133: 293304.
  • 130
    Dietzen DJ, Page KL, Tetzloff TA. Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity. Blood 2004; 103: 303844.
  • 131
    Mandal SK, Iakhiaev A, Pendurthi UR, Rao LV. Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol. Blood 2005; 105: 15360.
  • 132
    Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998; 141: 90515.
  • 133
    Key NS, Bach RR. Tissue factor as a therapeutic target. Thromb Haemost 2001; 85: 3756.